A phase I study of CD25/regulatory T-cell-depleted donor lymphocyte infusion for relapse after allogeneic stem cell transplantation

Donor lymphocyte infusions are used to treat relapse after allogeneic hematopoietic stem cell transplantation, but responses are inadequate. In addition to effector cells, infusions contain CD25(+) regulatory T cells (Treg) that may suppress graft-versus-tumor responses. We undertook a phase I study...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Haematologica
Autors principals: Nikiforow, Sarah, Kim, Haesook T., Daley, Heather, Reynolds, Carol, Jones, Kyle Thomas, Armand, Philippe, Ho, Vincent T., Alyea, Edwin P., Cutler, Corey S., Ritz, Jerome, Antin, Joseph H., Soiffer, Robert J., Koreth, John
Format: Artigo
Idioma:Inglês
Publicat: Ferrata Storti Foundation 2016
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5046655/
https://ncbi.nlm.nih.gov/pubmed/27354021
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2015.141176
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars